Thomas Catinazzo, Chief Financial Officer at Relay Therapeutics, Inc. (RLAY), sold 19,858 shares at $8.51 ($170K) on 2024-07-29, disclosed to the SEC on 2024-07-31.
Scheduled sale ($170k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.51 | 9,078 | $77K | 45.6% |
| 2 | $8.51 | 9,078 | $77K | 45.6% |
| 3 | $8.85 | 1,702 | $15K | 8.9% |
| Total | $8.54 avg | 19,858 | $170K | 100% |
| Filing → |
| RLAY | SELL | 2026-07-30 | $27K | — | Filing → |
| RLAY | SELL | 2026-07-08 | $331K | — | Filing → |
| RLAY | SELL | 2026-06-24 | $3.2M | — | Filing → |